Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Somerville

Showing results (151-160 of 166) with videos related to

Pageof 17
Sort By:
BJU International|June 25, 2011
Usefulness of prostate-specific antigen (PSA) rise as a marker of prostate cancer in men treated with dutasteride: lessons from the REDUCE studyMichael Marberger, Stephen J Freedland, Gerald L Andriole, et al.
Contemporary Clinical Trials|June 19, 2007
Delay in the progression of low-risk prostate cancer: rationale and design of the Reduction by Dutasteride of Clinical Progression Events in Expectant Management (REDEEM) trialNeil Fleshner, Leonard G Gomella, Michael S Cookson, et al.
The Plant Cell|October 9, 2002
Expression profile analysis of the low-oxygen response in Arabidopsis root culturesErik Jan Klok, Iain W Wilson, Dale Wilson, et al.
Molecular Plant|October 15, 2009
A lesion-mimic syntaxin double mutant in Arabidopsis reveals novel complexity of pathogen defense signalingZiguo Zhang, Andrea Lenk, Mats X Andersson, et al.
Nano Letters|October 12, 2011
A scheme for detecting every single target molecule with surface-enhanced Raman spectroscopyEric C Le Ru, Johan Grand, Idrissa Sow, et al.
Nature|October 31, 2003
SNARE-protein-mediated disease resistance at the plant cell wallNicholas C Collins, Hans Thordal-Christensen, Volker Lipka, et al.
Nature Genetics|May 30, 2006
Conserved requirement for a plant host cell protein in powdery mildew pathogenesisChiara Consonni, Matthew E Humphry, H Andreas Hartmann, et al.
American Journal of Clinical Dermatology|October 29, 2021
Tapinarof Cream 1% for Extensive Plaque Psoriasis: A Maximal Use Trial on Safety, Tolerability, and PharmacokineticsJohn E Jett, Michael McLaughlin, Mark S Lee, et al.
Lancet (London, England)|October 7, 2018
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trialAdrian F Hernandez, Jennifer B Green, Salim Janmohamed, et al.
The New England Journal of Medicine|April 2, 2010
Effect of dutasteride on the risk of prostate cancerGerald L Andriole, David G Bostwick, Otis W Brawley, et al.
Pageof 17

Showing results (151-160 of 166) with videos related to

Sort By:
Pageof 17
BJU International|June 25, 2011
Usefulness of prostate-specific antigen (PSA) rise as a marker of prostate cancer in men treated with dutasteride: lessons from the REDUCE studyMichael Marberger, Stephen J Freedland, Gerald L Andriole, et al.
Contemporary Clinical Trials|June 19, 2007
Delay in the progression of low-risk prostate cancer: rationale and design of the Reduction by Dutasteride of Clinical Progression Events in Expectant Management (REDEEM) trialNeil Fleshner, Leonard G Gomella, Michael S Cookson, et al.
The Plant Cell|October 9, 2002
Expression profile analysis of the low-oxygen response in Arabidopsis root culturesErik Jan Klok, Iain W Wilson, Dale Wilson, et al.
Molecular Plant|October 15, 2009
A lesion-mimic syntaxin double mutant in Arabidopsis reveals novel complexity of pathogen defense signalingZiguo Zhang, Andrea Lenk, Mats X Andersson, et al.
Nano Letters|October 12, 2011
A scheme for detecting every single target molecule with surface-enhanced Raman spectroscopyEric C Le Ru, Johan Grand, Idrissa Sow, et al.
Nature|October 31, 2003
SNARE-protein-mediated disease resistance at the plant cell wallNicholas C Collins, Hans Thordal-Christensen, Volker Lipka, et al.
Nature Genetics|May 30, 2006
Conserved requirement for a plant host cell protein in powdery mildew pathogenesisChiara Consonni, Matthew E Humphry, H Andreas Hartmann, et al.
American Journal of Clinical Dermatology|October 29, 2021
Tapinarof Cream 1% for Extensive Plaque Psoriasis: A Maximal Use Trial on Safety, Tolerability, and PharmacokineticsJohn E Jett, Michael McLaughlin, Mark S Lee, et al.
Lancet (London, England)|October 7, 2018
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trialAdrian F Hernandez, Jennifer B Green, Salim Janmohamed, et al.
The New England Journal of Medicine|April 2, 2010
Effect of dutasteride on the risk of prostate cancerGerald L Andriole, David G Bostwick, Otis W Brawley, et al.
Pageof 17